TOBI

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug TOBI contains one active pharmaceutical ingredient (API):

1 Tobramycin UNII VZ8RRZ51VK - TOBRAMYCIN

Tobramycin is an aminoglycoside antibiotic produced by Streptomyces tenebrarius. It acts primarily by disrupting protein synthesis leading to altered cell membrane permeability, progressive disruption of the cell envelope and eventual cell death. It is bactericidal at concentrations equal to or slightly greater than inhibitory concentrations. Read about Tobramycin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TOBI Podhaler Inhalation powder, hard capsule	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01GB01	Tobramycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01G Aminoglycoside antibacterials → J01GB Other aminoglycosides
Discover more medicines within J01GB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10066T, 10074F, 5442K
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526513030077514, 541519110016417
Country: CA	Health Products and Food Branch	Identifier(s): 02239630, 02365154
Country: EE	Ravimiamet	Identifier(s): 1553879, 1553880, 1553891
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 10652002, 63689
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 003861, 586241
Country: FR	Base de données publique des médicaments	Identifier(s): 60565723, 65832685
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 195371, 41252
Country: IE	Health Products Regulatory Authority	Identifier(s): 88370, 88373, 88882
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4922, 6965
Country: IT	Agenzia del Farmaco	Identifier(s): 034767018
Country: JP	医薬品医療機器総合機構	Identifier(s): 6123700G1026
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1061964, 1061965, 1061966
Country: MT	Medicines Authority	Identifier(s): MA1507/02201
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 161M2004
Country: NL	Z-Index G-Standaard	Identifier(s): 14675595
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 59986, 98248
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 15591, 9549
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100315203
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68686001, W68686002, W68686003
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8698856520685
Country: US	FDA, National Drug Code	Identifier(s): 0078-0494, 0078-0630, 49502-346
Country: ZA	Health Products Regulatory Authority	Identifier(s): A40/20.1.1/0522